General
Preferred name
NOVOBIOCIN SODIUM
Synonyms
Cathomycin ()
Albamycin ()
Albamycinsodium ()
Novobiocin sodium salt ()
Novobiocin Na+ ()
Albamycin (sodium) ()
Cathomycin (sodium) ()
Novobiocin (Sodium) ()
NOVOBIOCIN ()
Novobiocin Sodium (NSC 2382) ()
Albamycin,Cathomycin,NSC 2382 ()
NSC-2382 ()
Novobiocin, monosodium salt ()
Vulcamycin ()
Sodium novobiocin ()
Novobiocin monosodium salt ()
Spheromycin ()
Novobiocin (sodium salt) ()
P&D ID
PD001827
CAS
1476-53-5
303-81-1
Tags
available
drug
Drug Status
approved
withdrawn
Max Phase
4.0
Drug indication
Antibacterial
First approval
1964
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Compound Sets
11
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
MedChem Express Bioactive Compound Library
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
23
Properties
(calculated by RDKit )
Molecular Weight
634.21
Hydrogen Bond Acceptors
11
Hydrogen Bond Donors
4
Rotatable Bonds
8
Ring Count
4
Aromatic Ring Count
3
cLogP
0.0
TPSA
202.84
Fraction CSP3
0.39
Chiral centers
4.0
Largest ring
6.0
QED
0.15
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
DNA Damage/DNA Repair
Membrane Transporter/Ion Channel
Anti-infection
Apoptosis
Cell Cycle/DNA Damage
Metabolic Enzyme/Protease
Target
ABCG2
DNA gyrase
Bile salt export pump
Topo I
antibiotic
Bacterial
DNA/RNA Synthesis
HSP
Orthopoxvirus
Antineoplastic and Immunosuppressive Antibiotics,Topoisomerase
MOA
ABC inhibitor
DNA gyrase inhibitor
Potassium Channel inhibitor
Topoisomerase inhibitor
Source data